Infinity to Present at the J.P. Morgan Annual Healthcare Conference
JPMorgan Healthcare Conference 2013
CAMBRIDGE, Mass. -- December 31, 2012
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the J.P.
Morgan 31^st Annual Healthcare Conference on January 7, 2013, at 10:00 a.m. ET
in San Francisco, CA. A live webcast of this Infinity presentation will be
accessible on the Investors/Media section of Infinity's website at
www.infi.com, and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to
discover, develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Press spacebar to pause and continue. Press esc to stop.